G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis
- PMID: 28272905
- DOI: 10.1080/00365521.2017.1298834
G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis
Abstract
Aim: To investigate the levels of G protein-coupled receptor 55 (GPR55) expression in colonic tissue of inflammatory bowel disease (IBD) patients and healthy controls, and its potential implication in IBD treatment.
Methods: Fifty patients were enrolled in our prospective study: n = 21 with Crohn's disease (CD) and n = 16 with ulcerative colitis (UC); 19 women and 18 men. Control consisted of 13 non-IBD patients. In each subject, two biopsies were taken from different colonic locations. In IBD patients, biopsies both from endoscopically inflamed and non-inflamed areas were drawn and the development of inflammation confirmed in histopathological examination. GPR55 mRNA and protein expression were measured using real-time PCR and Western blot, respectively.
Results: GPR55 expression at mRNA and protein level was detected in all samples tested. The level of GPR55 mRNA expression in non-inflamed colonic areas was comparable in all analyzed groups (p = .2438). However, in the inflamed tissues GPR55 mRNA expression was statistically significantly (p < .0001) higher (6.9 fold) in CD patients compared to UC. Moreover, CD patients manifested higher (12.5 fold) GPR55 mRNA expression in inflamed compared with non-inflamed colonic tissues (p < .0001). Although no significant differences were stated, GPR55 protein level tends to decrease in IBD as compared to control.
Conclusions: Different patterns of GPR55 expression at mRNA level were observed in IBD patients. We speculate that GPR55 is crucial for the mucosal inflammatory processes in IBD, particularly in CD and its expression may affect disease severity, and response to treatment. The GPR55 receptors may become an attractive target for novel therapeutic strategies in IBD.
Keywords: Crohn’s disease; G protein-coupled receptor 55; endocannabinoid system; inflammatory bowel diseases; ulcerative colitis.
Similar articles
-
G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.J Gastrointestin Liver Dis. 2017 Mar;26(1):29-35. doi: 10.15403/jgld.2014.1121.261.gpr. J Gastrointestin Liver Dis. 2017. PMID: 28338111
-
Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.J Crohns Colitis. 2013 Sep;7(8):622-30. doi: 10.1016/j.crohns.2012.08.015. Epub 2012 Sep 24. J Crohns Colitis. 2013. PMID: 23014361
-
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.Inflamm Bowel Dis. 2008 Apr;14(4):437-45. doi: 10.1002/ibd.20339. Inflamm Bowel Dis. 2008. PMID: 18088064
-
The contribution of long non-coding RNAs in Inflammatory Bowel Diseases.Dig Liver Dis. 2017 Oct;49(10):1067-1072. doi: 10.1016/j.dld.2017.08.003. Epub 2017 Aug 9. Dig Liver Dis. 2017. PMID: 28869157 Review.
-
microRNA in inflammatory bowel disease at a glance.Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):140-148. doi: 10.1097/MEG.0000000000001815. Eur J Gastroenterol Hepatol. 2021. PMID: 32558695 Review.
Cited by
-
Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.Int J Mol Sci. 2023 Sep 28;24(19):14677. doi: 10.3390/ijms241914677. Int J Mol Sci. 2023. PMID: 37834122 Free PMC article. Review.
-
Cannabis Pharmacogenomics: A Path to Personalized Medicine.Curr Issues Mol Biol. 2023 Apr 17;45(4):3479-3514. doi: 10.3390/cimb45040228. Curr Issues Mol Biol. 2023. PMID: 37185752 Free PMC article. Review.
-
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.Front Immunol. 2021 Dec 22;12:790803. doi: 10.3389/fimmu.2021.790803. eCollection 2021. Front Immunol. 2021. PMID: 35003109 Free PMC article.
-
Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation.Int J Mol Sci. 2021 Dec 11;22(24):13328. doi: 10.3390/ijms222413328. Int J Mol Sci. 2021. PMID: 34948125 Free PMC article.
-
Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation.Front Cardiovasc Med. 2021 Nov 29;8:773473. doi: 10.3389/fcvm.2021.773473. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34912867 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical